Sage Therapeutics' GAAP loss for 9M 2021 was $333.18 million, down 9.7% from $368.822 million in the prior year. Revenues fell 6.9% to $4.666 million from $5.014 million a year earlier.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept